Table 1.
Descriptive statistics of study population in 2020 and 2019: absolute numbers or mean values (95%-CI), respectively, as well as percentages are given.
| Overall |
New onset DM |
Already diagnosed |
|||||
|---|---|---|---|---|---|---|---|
| 2020 | 2019 | 2020 | 2019 | 2020 | 2019 | ||
| n | 52 | 73 | 12 (23.1%) | 18 (24.65%) | 40 (76.9%) | 55 (75.34%) | |
| Sex | Male | 21 (40.4%) | 36 (49.3%) | 6 (50%) | 11 (61.1%) | 15 (37.5%) | 25 (46.3%) |
| Female | 31 (59.6%) | 37 (50.7%) | 6 (50%) | 7 (38.9%) | 25 (62.5%) | 29 (53.7%) | |
| Age | <6 years | 16 (30.8%) | 13 (17.8%) | 6 (50%) | 5 (27.8%) | 10 (25%) | 8 (14.8%) |
| 6–11 years | 11 (21.2%) | 19 (26%) | 3 (25%) | 6 (33.3%) | 8 (20%) | 12 (22.2%) | |
| 12–18 | 25 (48%) | 41 (56,2%) | 3 (25%) | 7 (38.9%) | 22 (55%) | 34 (63%) | |
| Duration of symptoms | Days | 6 (50%) | 8 (40%) | 2 (28.6%) | 3 (23.1%) | 4 (80%) | 5 (71.4%) |
| 1 week | 2 (16.7%) | 4 (20%) | 2 (28.6%) | 4 (30.8%) | 0 | 0 | |
| Few weeks | 2 (16.7%) | 6 (30%) | 2 (28.6%) | 4 (30.8%) | 0 | 2 (28.6%) | |
| Few months | 2 (16.7%) | 2 (10%) | 1 (14.3%) | 2 (15.4%) | 1 (20%) | 0 | |
| Variables | |||||||
| Age (years) | 9.48 (8.12–10.84) | 10.64 (9.61–11.67) | 7.50 (4.38–10.62) | 9.24 (6.77–11.7) | 10.07 (8.55–11.6) | 11.11 (9.95–12.27) | |
| Age at manifestation (years) | 6.4 (5.2–7.6) | 7.13 (6.02–8.23) | 7.50 (4.38–10.62) | 9.24 (6.77–11.7) | 6.08 (4.75–7.4) | 6.58 (5.36–7.81) | |
| BMI-SDS | 0.68 (0.23–1.13) | 0.62 (0.27–0.97) | 0.19 (−1.08–1.45) | −0.38 (−1.07–0.31) | 0.83 (0.35–1.30) | 0.95 (0.57–1.33) | |
| Blood-glucose at admittance (mmol/l) | 16.69 (14.46–18.92) | 17.80 (15.51–20.09) | 22.27 (17.94–26.60) | 24.89 (20.29–29.51) | 15.02 (12.58–17.46) | 15.39 (13.01–17.77) | |
| pH-level | 7.2702 (7.2074–7.3330) | 7.3074 (7.2571–7.3578) | 7.1668 (7.0394–7.2941) | 7.2661 (7.1619–7.3704) | 7.3241 (7.2590–7.3893) | 7.3344 (7.2822–7.3867) | |
| Base excess (mmol/l) | −8,01 (−11,56–(−4,47)) | −6,23 (−8,82–(−3,64)) | −15,08 (−22,62–(−7,55)) | −6,46 (−10,89–(−2,04)) | −4,75 (−8,25–(−1,25)) | −6,06 (−9,47–(−2,64)) | |
| HbA1c (mmol/mol) | 88.98 (82.34–95.61) | 93.82 (83.47–104.16) | 98.73 (85.67–111.79) | 100.66 (89.65–111.66) | 82.82 (76.28–89.35) | 86.98 (68.71–105.24) | |
| HbA1c (%) | 10.27 (9.68–10.86) | 10.9 (10.25–11.55) | 11.18 (9.98–12.38) | 11.45 (10.55–12.35) | 9.72 (9.15–10.28) | 10.51 (9.53–11.49) | |
| Days in hospital | 10.13 (8.62–11.65) | 9.86 (8.71–11.02) | 17.33 (15.06–19.61) | 14.56 (13.32–15.79) | 7.98 (6.75–9.20) | 8.41 (7.15–9.66) | |